Inventor · disambiguated record
Jeff Zablocki
Also filed as: ZABLOCKI JEFF · ZABLOCKI JEFF A
157 granted patents·47 pending applications·2,375 citations·filing 1999–2023
99Inventor score
Files withCV THERAPEUTICS INC64GILEAD SCIENCES INC62GILEAD PALO ALTO INC21ZABLOCKI JEFF9KOLTUN DMITRY6
Top patents by PatentIndex Score
204 records- 0198US10640499B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted May 5, 2020·32 cites·10 claims
- 0298US10370342B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted Aug 6, 2019·30 cites·13 claims
- 0398US9670205B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2016·Granted Jun 6, 2017·100 cites·16 claims
- 0498US7144872B2N-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2005·Granted Dec 5, 2006·50 cites·27 claims
- 0597US11827609B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2021·Granted Nov 28, 2023·4 cites·11 claims
- 0697US7553823B2C-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2006·Granted Jun 30, 2009·48 cites·8 claims
- 0796US10285990B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted May 14, 2019·11 cites·6 claims
- 0896US7732595B2Process for preparing an A2A-adenosine receptor agonist and its polymorphsGILEAD PALO ALTO INC·Filed 2007·Granted Jun 8, 2010·40 cites·13 claims
- 0996US7655637B2N-pyrazole A2A receptor agonistsGILEAD PALO ALTO INC·Filed 2006·Granted Feb 2, 2010·31 cites·19 claims
- 1096US7183264B2N-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2003·Granted Feb 27, 2007·48 cites·22 claims
- 1196US6825349B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2002·Granted Nov 30, 2004·95 cites·31 claims
- 1296US6642210B12-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Nov 4, 2003·61 cites·18 claims
- 1396US6552023B2Aralkyl substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Apr 22, 2003·64 cites·24 claims
- 1496US6548548B2ABCA-1 elevating compoundsCV THERAPEUTICS INC·Filed 2001·Granted Apr 15, 2003·61 cites·39 claims
- 1596US6403567B1N-pyrazole A2A adenosine receptor agonistsCV THERAPEUTICS INC·Filed 1999·Granted Jun 11, 2002·112 cites·13 claims
- 1695US8575353B2Compounds for the treatment of addictionGILEAD SCIENCES INC·Filed 2013·Granted Nov 5, 2013·23 cites·26 claims
- 1795US7671192B2Process for preparing an A2A-adenosine receptor agonist and its polymorphsGILEAD PALO ALTO INC·Filed 2007·Granted Mar 2, 2010·37 cites·5 claims
- 1895US7625881B2Prodrugs of A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2006·Granted Dec 1, 2009·31 cites·17 claims
- 1995US7317017B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2005·Granted Jan 8, 2008·22 cites·15 claims
- 2095US7109180B2C-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2004·Granted Sep 19, 2006·43 cites·8 claims
- 2195US6770634B1C-pyrazole a2a receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Aug 3, 2004·46 cites·6 claims
- 2295US6677336B2Substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Jan 13, 2004·59 cites·34 claims
- 2395US6573264B1Heteroaryl alkyl piperazine derivativesCV THERAPEUTICS INC·Filed 2000·Granted Jun 3, 2003·60 cites·41 claims
- 2494US9371329B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2014·Granted Jun 21, 2016·26 cites·2 claims
- 2594US8952034B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2010·Granted Feb 10, 2015·29 cites·18 claims
- 2694US8586732B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Nov 19, 2013·29 cites·35 claims
- 2794US6977300B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Dec 20, 2005·69 cites·25 claims
- 2893US11897878B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Feb 13, 2024·2 cites·65 claims
- 2993US8440665B2Apoptosis signal-regulating kinase inhibitorsCORKEY BRITTON·Filed 2011·Granted May 14, 2013·21 cites·5 claims
- 3093US8106183B2Process for preparing an A2A-adenosine receptor agonist and its polymorphsZABLOCKI JEFF·Filed 2010·Granted Jan 31, 2012·20 cites·9 claims
- 3193US7956179B2Process for preparing an A2A-adenosine receptor agonist and its polymorphsGILEAD SCIENCES INC·Filed 2010·Granted Jun 7, 2011·18 cites·7 claims
- 3293US7741331B2A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Jun 22, 2010·16 cites·8 claims
- 3393US6605597B1Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivativesCV THERAPEUTICS INC·Filed 1999·Granted Aug 12, 2003·97 cites·13 claims
- 3492US11925631B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Mar 12, 2024·2 cites·37 claims
- 3592US11124487B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2019·Granted Sep 21, 2021·8 cites·14 claims
- 3692US9296782B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2013·Granted Mar 29, 2016·13 cites·16 claims
- 3792US8697863B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Apr 15, 2014·13 cites·11 claims
- 3892US6451798B2Substituted alkyl piperazine derivativesCV THERAPEUTICS INC·Filed 2001·Granted Sep 17, 2002·26 cites·26 claims
- 3992US6294522B1N6 heterocyclic 8-modified adenosine derivativesCV THERAPEUTICS INC·Filed 1999·Granted Sep 25, 2001·122 cites·24 claims
- 4092US6214807B1C-pyrazole 2A A receptor agonistsCV THERAPEUTICS INC·Filed 1999·Granted Apr 10, 2001·74 cites·33 claims
- 4191US9676760B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 13, 2017·7 cites·2 claims
- 4291US9610299B2Compounds for the treatment of addictionGILEAD SCIENCES INC·Filed 2015·Granted Apr 4, 2017·8 cites·3 claims
- 4391US9598435B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 21, 2017·9 cites·13 claims
- 4491US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 4591US7125993B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Oct 24, 2006·37 cites·47 claims
- 4691US6946449B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2002·Granted Sep 20, 2005·26 cites·30 claims
- 4791US6855818B2C-pyrazole A2A receptor agonistsCV THERAEPUTICS INC·Filed 2001·Granted Feb 15, 2005·45 cites·1 claims
- 4890US9193694B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Nov 24, 2015·11 cites·11 claims
- 4990US9000015B2Compounds for the treatment of addictionGILEAD SCIENCES INC·Filed 2013·Granted Apr 7, 2015·9 cites·4 claims
- 5090US8268988B2Process for preparing an A2A-adenosine receptor agonist and its polymorphsZABLOCKI JEFF·Filed 2011·Granted Sep 18, 2012·10 cites·16 claims
Showing the top 50 of 204 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jeff Zablocki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →